Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2020	Dec. 31, 2019
Assets:
Agency securities, at fair value (including pledged securities of $64,154 and $92,608, respectively)	$ 70,292	$ 98,516
Agency securities transferred to consolidated variable interest entities, at fair value (pledged securities)	358	371
Credit risk transfer securities, at fair value (including pledged securities of $360 and $309, respectively)	574	976
Non-Agency securities, at fair value (including pledged securities of $437 and $0, respectively)	552	579
U.S. Treasury securities, at fair value (pledged securities)	3,721	97
Cash and cash equivalents	1,289	831
Restricted cash	1,978	451
Derivative assets, at fair value	664	190
Receivable for investment securities sold	0	0
Receivable under reverse repurchase agreements	4,938	10,181
Goodwill and other intangible assets, net	526	526
Other assets	245	364
Total assets	85,137	113,082
Liabilities:
Repurchase Agreements	66,540	89,182
Debt of consolidated variable interest entities, at fair value	214	228
Payable for investment securities purchased	3,273	2,554
Derivative liabilities, at fair value	138	6
Dividends payable	113	104
Obligation to return securities borrowed under reverse repurchase agreements, at fair value	4,886	9,543
Accounts payable and other liabilities	175	424
Total liabilities	75,339	102,041
Stockholders' equity:
Preferred Stock - aggregate liquidation preference of $1,538 and $963, respectively	1,489	932
Common stock - $0.01 par value; 900 shares authorized; 567.7 and 540.9 shares issued and outstanding, respectively	6	5
Additional paid-in capital	14,334	13,893
Retained deficit	(6,592)	(3,886)
Accumulated other comprehensive income (loss)	561	97
Total stockholders' equity	9,798	11,041
Total liabilities and stockholders' equity	$ 85,137	$ 113,082